These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers. Shepherd G Am J Health Syst Pharm; 2006 Oct; 63(19):1828-35. PubMed ID: 16990629 [TBL] [Abstract][Full Text] [Related]
3. Treatment for calcium channel blocker poisoning: a systematic review. St-Onge M; Dubé PA; Gosselin S; Guimont C; Godwin J; Archambault PM; Chauny JM; Frenette AJ; Darveau M; Le Sage N; Poitras J; Provencher J; Juurlink DN; Blais R Clin Toxicol (Phila); 2014 Nov; 52(9):926-44. PubMed ID: 25283255 [TBL] [Abstract][Full Text] [Related]
4. Glucagon therapy for beta-blocker overdose. Peterson CD; Leeder JS; Sterner S Drug Intell Clin Pharm; 1984 May; 18(5):394-8. PubMed ID: 6144498 [TBL] [Abstract][Full Text] [Related]
5. An Overview of Hyperinsulinemic-Euglycemic Therapy in Calcium Channel Blocker and β-blocker Overdose. Krenz JR; Kaakeh Y Pharmacotherapy; 2018 Nov; 38(11):1130-1142. PubMed ID: 30141827 [TBL] [Abstract][Full Text] [Related]
6. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Cole JB; Arens AM; Laes JR; Klein LR; Bangh SA; Olives TD Am J Emerg Med; 2018 Oct; 36(10):1817-1824. PubMed ID: 29452919 [TBL] [Abstract][Full Text] [Related]
7. A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia. Love JN; Sachdeva DK; Bessman ES; Curtis LA; Howell JM Chest; 1998 Jul; 114(1):323-6. PubMed ID: 9674488 [TBL] [Abstract][Full Text] [Related]
9. Glucagon therapy in the treatment of symptomatic bradycardia. Love JN; Howell JM Ann Emerg Med; 1997 Jan; 29(1):181-3. PubMed ID: 8998104 [TBL] [Abstract][Full Text] [Related]
11. Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning. Cole JB; Corcoran JN; Engebretsen KM; Stellpflug SJ J Med Toxicol; 2020 Apr; 16(2):212-221. PubMed ID: 31981076 [TBL] [Abstract][Full Text] [Related]
12. Development and Feasibility of a Porcine Model of Amlodipine Toxicity. Boley SP; Mackenzie RB; LeRoy JM; Engebretsen KM; Stellpflug SJ J Med Toxicol; 2020 Jan; 16(1):61-66. PubMed ID: 31385194 [TBL] [Abstract][Full Text] [Related]
13. A Swine Model of Severe Propranolol Toxicity Permitting Direct Measurement of Brain Tissue Oxygenation. Orozco BS; Engebretsen KM; Holger JS; Stellpflug SJ J Med Toxicol; 2019 Jul; 15(3):178-183. PubMed ID: 30895518 [TBL] [Abstract][Full Text] [Related]
14. Too many pills to swallow: A case of a mixed overdose. Hopkins LE; Sunkersing J; Jacques A J Intensive Care Soc; 2017 Aug; 18(3):247-250. PubMed ID: 29118840 [TBL] [Abstract][Full Text] [Related]
15. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Graudins A; Lee HM; Druda D Br J Clin Pharmacol; 2016 Mar; 81(3):453-61. PubMed ID: 26344579 [TBL] [Abstract][Full Text] [Related]
16. A comparison of vasopressin and glucagon in beta-blocker induced toxicity. Holger JS; Engebretsen KM; Obetz CL; Kleven TL; Harris CR Clin Toxicol (Phila); 2006; 44(1):45-51. PubMed ID: 16496493 [TBL] [Abstract][Full Text] [Related]